Zobrazeno 1 - 9
of 9
pro vyhledávání: '"LUCA MARMIROLI"'
Autor:
Antonella Bufacchi, Orietta Caspiani, Giulia Rambaldi, Luca Marmiroli, Giuseppe Giovinazzo, Mattia Polsoni
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-8 (2020)
Abstract Purpose Retrospective analysis of volumetric modulated arc therapy treatment plans to investigate qualitative, possible, clinical consequences of the use of AAA versus AXB in nasopharyngeal cancer (NPC) cases. Methods The dose distribution o
Externí odkaz:
https://doaj.org/article/d108b8a1a0c248ff9e298924b62f0368
Autor:
VITALIANA DE SANCTIS, GIUSEPPE FACONDO, GIANLUCA VULLO, DIMITRI ANZELLINI, GIUSEPPE SANGUINETI, ALESSIA NARDANGELI, LUCA MARMIROLI, FRANCESCA TORTORETO, PIERCARLO GENTILE, IVAN ANNESSI, VITTORIO DONATO, CINZIA CHIOSTRINI, VINCENZO TOMBOLINI, FRANCESCA DE FELICE, MAURIZIO VALERIANI, MATTIA FALCHETTO OSTI
Publikováno v:
Cancer Diagn Progn
Background/Aim: To evaluate the outcome and toxicities in patients with locally advanced cervical cancer (LACC) treated with radiochemotherapy and intracavitary brachytherapy. Patients and Methods: This study included 67 patients with LACC treated be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305f139bdcdca5c49c10c368a67f30c8
https://europepmc.org/articles/PMC9949546/
https://europepmc.org/articles/PMC9949546/
Autor:
Orietta Caspiani, Luca Marmiroli, A. Bufacchi, Mattia Polsoni, Giuseppe Giovinazzo, Giulia Rambaldi
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-8 (2020)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Purpose Retrospective analysis of volumetric modulated arc therapy treatment plans to investigate qualitative, possible, clinical consequences of the use of AAA versus AXB in nasopharyngeal cancer (NPC) cases. Methods The dose distribution of 26 trea
Autor:
A. Bufacchi, Luca Marmiroli, R. Capparella, Stefania Delle Canne, R. Fragomeni, Tiziana Malatesta, L. Begnozzi, Giorgio Arcangeli
Publikováno v:
Radiotherapy and Oncology. 92:68-75
Purpose Retrospective study of 3D clinical treatment plans based on radiobiological considerations in the choice of the reference dose level from tumor dose–volume histograms. Methods and materials When a radiation oncologist evaluates the 3D dose
Autor:
Patrizio Pasqualetti, Alfredo Fabiano, Luca Marmiroli, Diego Signorelli, Domenico Corsi, Radici M, Angelo Camaioni, Giorgio Mazzarella, Ilaria Simonelli, Marco Ciaparrone, Curzio Pianelli, Piera Catalano, A. Mecozzi, Giulio Bicciolo, Luca de Campora, Orietta Caspiani
Publikováno v:
Oncology. 89(4)
Objective: ERCC1 (excision repair cross-complementation group 1) expression predicts survival in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with chemoradiation. In order to evaluate the predictive role in the
Publikováno v:
Tumori Journal. 84:S7-S9
It is extremely important to deliver treatments, both in medical oncology and in radiation oncology, in compliance with the due dose intensity, in order to achieve the best results in terms of clinical response and local control and, often, also in t
Autor:
Luca, Marmiroli, Giovanna, Salvi, Adolfo, Caiazza, Luigi, Di Rienzo, Mariangela, Massaccesi, Paola, Murino, Gabriella, Macchia
Publikováno v:
Rays. 30(2)
Radiation-induced xerostomia consists in the chronic dryness of the mouth caused by parotid gland irradiation. Parotid glands produce approximately 60% of saliva while the rest is secreted by submandibular and accessory salivary glands. Methods of me
Publikováno v:
Rays. 27(3)
The most recent clinical studies are increasingly concerned about the molecular factors in terms of prognosis, predictivity of response to treatments and development of novel, targeted therapeutic strategies. An integrated diagnostic and prognostic a
Autor:
Antonio, Grieco, Stefania, Marcoccia, Luca, Miele, Luca, Marmiroli, Giuseppe, Caminiti, Enzo, Ragazzoni, Antonio Raffaele, Cotroneo, Giampiero Ausili, Cefaro, Gian Lodovico, Rapaccini, Giovanni, Gasbarrini
Publikováno v:
Hepato-gastroenterology. 50(49)
Transarterial chemoembolization is widely used for palliative treatment of hepatocellular carcinoma, but patient's characteristics associated with maximal benefit are still undefined.In 81 cirrhotic patients with unresectable hepatocellular carcinoma